Aridis pharmaceuticals, inc. (ARDS)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Sep'17Jun'17
Revenue:
Grant revenue

-

-

0

0

1,022

-

1,022

22

-

-

-

Total revenue

-

-

-

-

-

-

-

-

322

22

22

Operating expenses:
Research and development

4,917

4,301

6,011

6,653

7,118

5,582

6,907

3,885

6,626

4,859

3,170

General and administrative

1,639

1,388

1,384

1,613

1,641

1,386

735

687

1,066

649

829

Total operating expenses

6,556

5,689

7,395

8,266

8,759

6,968

7,642

4,572

7,692

5,508

3,999

Loss from operations

-6,556

-5,689

-7,395

-8,266

-7,737

-5,577

-6,620

-4,550

-7,370

-5,486

-3,977

Other income (expense):
Interest and other income, net

61

82

90

69

116

159

119

68

74

64

72

Change in fair value of warrant liability

-

-

-

-

-

0

1,388

-3,058

38

-

2,178

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-4

-

Share of loss from equity method investment

-9

-41

-282

-186

-442

-

-20

-

-

-

-

Net loss

-6,504

-5,648

-7,587

-8,383

-8,063

-5,438

-7,909

-1,424

-7,334

-5,418

-6,083

Preferred dividends

-

-

-

-

-

0

5

535

817

788

701

Net loss available to common stockholders

-

-

-7,587

-8,383

-

-5,438

-7,914

-1,959

-8,151

-6,206

-6,784

Weighted-average common shares outstanding used in computing net loss per share available to common stockholders
Weighted-average common shares outstanding used in computing net loss, basic and diluted

8,919

-

-

-

8,105

-

-

-

-

-

-

Basic (in shares)

-

-

8,694

8,107

-

-

4,019

166

166

166

166

Diluted (in shares)

-

-

8,694

8,107

-

-

4,019

166

166

166

166

Basic (in dollars per share)

-

-

-0.87

-1.03

-

-

-1.97

-8.56

-44.08

-32.57

-36.56

Diluted (in dollars per share)

-

-

-0.87

-1.03

-

-

-1.97

-8.56

-44.08

-32.57

-36.56

Preferred dividends:
Basic (in dollars per share)

-

-

-

-

-

-

-

3.22

4.91

4.73

4.21

Diluted (in dollars per share)

-

-

-

-

-

-

-

3.22

4.91

4.73

4.21

Net loss per share available to common stockholders:
Net loss per share, basic and diluted

-0.73

-

-

-

-0.99

-

-

-

-

-

-

Basic (in dollars per share)

-

-

-0.87

-1.03

-

-

-1.97

-11.78

-48.99

-37.30

-40.77

Diluted (in dollars per share)

-

-

-0.87

-1.03

-

-

-1.97

-11.78

-48.99

-37.30

-40.77